Discontinuation report ZOSTAVAX II
| Report ID | 159386 |
| Drug Identification Number | 02375516 |
| Brand name | ZOSTAVAX II |
| Common or Proper name | (zoster vaccine live, attenuated [Oka/Merck], refrigerator-stable) powder for suspension for injection |
| Company Name | MERCK CANADA INC |
| Market Status | CANCELLED POST MARKET |
| Active Ingredient(s) | VARICELLA-ZOSTER VIRUS VACCINE LIVE ATTENUATED |
| Strength(s) | 19400PFU |
| Dosage form(s) | POWDER FOR SUSPENSION |
| Route of administration | SUBCUTANEOUS SUBCUTANEOUS |
| Packaging size | 1 dose vial |
| ATC code | J07BK |
| ATC description | VIRAL VACCINES |
| Reason for discontinuation | Business reasons |
| Anticipated discontinuation date | 2022-10-14 |
| Actual discontinuation date | 2022-10-14 |
| Remaining supply date | 2022-10-14 |
| Discontinuation status | Discontinued |
| Discontinuation decision reversal | No |
| Information on remaining supply | |
| Company comments | |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 16750 ROUTE TRANSCANADIENNE KIRKLAND, QUEBEC CANADA H9H 4M7 |
| Company contact information | 1-800-567-2594 medinfocanada@merck.com |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v1 | 2022-04-26 | English | Compare |
| v2 | 2022-04-26 | French | Compare |
| v3 | 2022-10-12 | English | Compare |
| v4 | 2022-10-14 | English | Compare |
| v5 | 2022-10-14 | French | Compare |
| v6 | 2022-10-15 | French | Compare |
Showing 1 to 6 of 6